Altria reported Q4 earnings that exceeded analyst expectations, with revenue steady at $5.27 billion and adjusted EPS up 3% to $5.12. However, shares fell by 2% due to market concerns about its 2025 outlook and a U.S. International Trade Commission ruling that found its NJOY vaping products violated patents held by Juul Labs. This ruling could threaten the future of NJOY devices, which saw significant volume growth. Despite these setbacks, Altria maintains a secure dividend yield of 8%, having raised payouts consistently for 55 years, making it potentially attractive for dividend-seeking investors.
Altria's Q4 earnings of $5.27 billion were slightly above estimates, but a patent violation regarding NJOY vapes has raised concerns over future product viability.
Shares of Altria fell 2% as investors reacted to the company's lackluster outlook for 2025, despite its solid market position and secure dividend yield of 8%.
The U.S. International Trade Commission's ruling against Altria regarding NJOY vapes represents a significant challenge, echoing past patent infringement issues that hampered product launches.
Altria's steady dividend increase over the last 55 years continues to attract investors, showcasing a commitment to shareholder returns amid market fluctuations.
Collection
[
|
...
]